About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT05426564

Exploratory Assessment of the Quantra® System in Adult ECMO Patients

This is a prospective, observational exploratory study of the performance of the Quantra System in adult patients that are undergoing an arterio-venous (AV), veno-venous (VV) ECMO or extra-corporeal l...

Lead sponsor: HemoSonics LLC•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

HemoSonics LLC

Collaborators

University of California, Irvine

Patients 18 years or older that are undergoing an arterio-venous (AV), veno-venous (VV) ECMO or extra-corporeal life support (ECLS) procedure will be enrolled in this prospective, observational exploratory study. From each enrolled subject, blood samples will be collected at multiple time points for analysis on the Quantra QPlus or QStat Cartridge in parallel with other assessments performed as standard of care.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Subject is \> 18 years.
•Subject is scheduled to undergo either VA or VV ECMO procedure or has been placed on VA or VV ECMO within 24 hours.
•Subject or subject's legally authorized representative (LAR) is willing to provide informed consent, either prospectively or by deferred consent.

Exclusion Criteria

•Subject is younger than 18 years of age.
•Subject is pregnant.
•Subject is incarcerated at the time of the study.
•Subject, or subject's legally authorized representative is unable or unwilling to provide informed consent.
•Subject is affected by a condition that, in the opinion of the treatment team, may pose additional risks.

Related studies

Association of Anti-factor Xa Activity With Venous Thromboembolism in Critically Ill Patients

NCT06357403 · Thrombosis, Pulmonary Embolism, and more

RECRUITINGPhase 2/3

Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies

NCT04924322 · Deep Venous Thrombosis

RECRUITINGPhase 4

Pharmaco Mechanical Thrombolysis Associated With Anticoagulation Compared With Anticoagulation in the Acute Phase of Very Symptomatic Proximal Venous Thrombosis of the Lower Limbs.

NCT06472518 · Iliofemoral Venous Thrombosis

RevCore for In Stent Thrombosis

NCT06394739 · In-stent Thrombosis

Autopsy and Photon Counting Computed Tomography to Evaluate Thromboses Related to Central Venous Catheters

NCT06417541 · Central Venous Catheter Thrombosis

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 15, 2023Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment10

Start dateSep 2022

Last updatedJun 15, 2023

Condition

Blood Loss Thrombosis Extracorporeal Circulation; Complications

Locations shown

University of California Irvine

Irvine, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 15, 2023Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions